ציין מניה או מטבע קריפטוגרפי בשורת החיפוש כדי לקבל סיכום
China Shineway Pharmaceutical Group Ltd
C1SChina Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd. Address: No. 168, Shiluan Street, Shijiazhuang, China, 051430
Analytics
מחיר יעד של וול סטריט
104.92 HKDיחס רווח למחיר
5.25תשואת דיבידנד
6.93 %השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
השנה הנוכחית
שנה שעברה
רבעון נוכחי
רבע אחרון
דמויות מפתח C1S
ניתוח דיבידנדים C1S
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–גידול דיבידנד במשך 5 שנים
123.00 %צמיחה מתמשכת
2 שניםיחס תשלום ממוצע של 5 שנים
62.00 %היסטוריית דיבידנדים C1S
שווי מניות C1S
פיננסיים C1S
תוצאות | 2019 | דינמיקה |